BioHealth News
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
Venlo, the Netherlands, April 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the first quarter…
Read More
MedCityNews: An Oveview of the Nation’s Largest SEED Fund
Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding…
Read More
Deloitte Acquires Gryphon Scientific Business to Expand Security, Science and Public Health Capabilities
Acquisition will strengthen Deloitte team with a complement of data-driven biosecurity detection, prevention and emergency response solutions ARLINGTON, Va., April 29, 2024 /PRNewswire/ -- Deloitte announced…
Read More
Pitchbook: The World’s Top Startup Cities
PitchBook’s VC Ecosystem Rankings compare global cities based on the size and maturity of their startup networks. The framework helps founders, operators and investors…
Read More
Venable Ranks Among American Lawyer Magazine’s Top 100 Firms
Washington, DC (April 17, 2024) – Venable LLP is pleased to announce that it has been named to American Lawyer magazine’s 2024 Am Law 100 list. The annual ranking…
Read More
AURP Wins Stage One of the U.S. Small Business Administration’s 2024 Growth Accelerator Fund Competition
AURP awarded $50,000 in prize money for equitable access to entrepreneurship WASHINGTON, DC, and TUCSON, AZ / ACCESSWIRE / April 24, 2024 / The U.S. Small…
Read More
Virginia Innovation Partnership Corporation (VIPC) Names Joe Benevento as President & CEO
Benevento to lead Virginia’s strategic authority that invests in startup companies, entrepreneurship ecosystems, university commercialization, innovation growth VIPC is well-positioned to lead Virginia in…
Read More
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read More
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
The first living recipient of a UThymoKidney, in conjunction with a heart pump implant, is recovering after a successful transplant This transplant builds on…
Read More
BISNOW: ‘Signs Of Rebound’ Emerging In Biotech, $11B In VC Funds To Kick-Start Recovery, Alexandria Says
April 23, 2024, Patrick Sisson, Bisnow National - One of the life sciences real estate’s biggest players sees a clear road to recovery, predicting…
Read More
AMPEL BioSolutions Selected as Member of Prestigious Federal Health Innovation ARPA-H Network
CHARLOTTESVILLE, VA – April 22, 2024 – AMPEL BioSolutions has been selected as a member - or "spoke" - of the Customer Experience Hub of ARPANET-H, a prestigious nationwide health innovation…
Read More
USP joins BARDA’s BioMaP-Consortium
Rockville, MD, April 22, 2024 – U.S. Pharmacopeia (USP) is honored to announce its selection as a member of the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium),…
Read More
Gaithersburg’s Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update
Shenzhen Salubris commits additional funding to continue research and development of novel, complex biologics First patient enrolled in RENEU-HF, the Phase 2 clinical trial…
Read More
Rockville’s DrFirst Acquires Myndshft Technologies to Revolutionize Medication Management by Addressing Both Pharmacy and Medical Benefits
Pioneering Move Unites Medical and Pharmacy Benefits, Enhancing Access, Affordability, and Adherence for Specialty Medications and Procedures ROCKVILLE, Md., April 18, 2024 /PRNewswire/ -- Healthcare technology pioneer DrFirst today…
Read More
Novavax to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom
April 18, 2024For Global Investor Audience Only Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across…
Read More